Breaking News, Financial News

Financial Report: WuXi PharmaTech

Revenues up 25% in the quarter

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

WuXi PharmaTech   4Q Revenues: $157.2 million (+25%) 4Q Earnings: $32.9 million (+38%) FY Revenues: $578.1 million (+16%) FY Earnings: $114.6 million (+32%) Comments: Laboratory Services revenue in the quarter grew 15% to $119.4 million, driven by drug discovery and development services, with China-based revenues up 18% to $95.8 million, and U.S.-based revenues up 6% to $23.6 million. Manufacturing Services revenue was up 73% to $37.8 million, driven by strong demand in both research manufac...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters